Last reviewed · How we verify
Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in HCV Positive in Liver Transplantation (CHASE)
This is an exploratory study to evaluate the impact of eliminating steroid administration upon viral HCV load at 12 months measured by quantitative serum HCV-RNA determination in patients transplanted for HCV cirrhosis.
Details
| Lead sponsor | Astellas Pharma Inc |
|---|---|
| Phase | Phase 2 |
| Status | COMPLETED |
| Enrolment | 138 |
| Start date | 2005-06 |
| Completion | 2008-06 |
Conditions
- Hepatitis C
- Liver Transplantation
Interventions
- Tacrolimus
- steroids, monoclonal anti-IL2R antibody
Primary outcomes
- Viral load of HCV at 12 months post transplantation — 12 months
Countries
Czechia, France, Germany, Italy, Poland, Spain, Sweden, United Kingdom